Enhanced delivery of antisense oligonucleotides with fluorophore-conjugated PAMAM dendrimers
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
PAMAM dendrimers are cationic polymers that have been used for the delivery of genes and oligonucleotides to cells. However, little is known about the behavior of dendrimer-nucleic acid complexes once they reach the cell interior. To pursue this issue, we prepared dendrimers conjugated with the fluorescent dye Oregon green 488. These were used in conjunction with oligonucleotides labeled with a red (TAMRA) fluorophore in order to visualize the sub-cellular distribution of the dendrimer-oligonucleotide complex and of its components by two-color digital fluorescence microscopy. The 2'-O:-methyl antisense oligonucleotide sequence used in these studies was designed to correct splicing at an aberrant intron inserted into a luciferase reporter gene; thus effective delivery of the antisense agent results in the expression of the reporter gene product. The dendrimer-oligonucleotide complex remained associated during the process of uptake into vesicular compartments and eventual entry into the nucleus. Since the pharmacological activity of the antisense compound was manifest under these conditions, it suggests that the dendrimer-oligonucleotide complex is functionally active. A surprising result of these studies was that the Oregon green 488-conjugated dendrimer was a much better delivery agent for antisense compounds than unmodified dendrimer. This suggests that coupling of relatively hydrophobic small molecules to PAMAM dendrimers may provide a useful means of enhancing their capabilities as delivery agents for nucleic acids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mechanism of oligonucleotide release from cationic liposomes.
Zelphati, O., & Szoka, F. C. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11493 · Cited by 634
Cited by
Nonviral vectors for gene delivery
Mintzer, M. A., & Simanek, E. E. (2009) · Chemical Reviews · doi:10.1021/cr800409e · Cited by 2,366
Dendrimers in biomedical applications—reflections on the field
SVENSON, S., & TOMALIA, D. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.018 · Cited by 1,919
Sapsford, K. E., Berti, L., & Medintz, I. L. (2006) · Angewandte Chemie International Edition · doi:10.1002/anie.200503873 · Cited by 1,561
Boas, U., & Heegaard, P. M. H. (2004) · Chemical Society Reviews · doi:10.1039/b309043b · Cited by 1,175
DUFES, C., UCHEGBU, I., & SCHATZLEIN, A. (2005) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2005.09.017 · Cited by 984
The influence of surface modification on the cytotoxicity of PAMAM dendrimers
Jevprasesphant, R. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00623-3 · Cited by 726
Dendrimer toxicity: Let's meet the challenge
Jain, K., Kesharwani, P., Gupta, U., & Jain, N. K. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.04.027 · Cited by 710
DNA-based therapeutics and DNA delivery systems: A comprehensive review
Patil, S. D., Rhodes, D. G., & Burgess, D. J. (2005) · The AAPS Journal · doi:10.1208/aapsj070109 · Cited by 630
Dendrimers in biomedical applications—reflections on the field
Svenson, S., & Tomalia, D. A. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.09.030 · Cited by 593
Dendrimers as versatile platform in drug delivery applications
Svenson, S. (2009) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2008.09.023 · Cited by 570
Hydrophobic modifications of cationic polymers for gene delivery
Liu, Z., Zhang, Z., Zhou, C., & Jiao, Y. (2010) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2010.04.007 · Cited by 432
ANTISENSE OLIGONUCLEOTIDES: FROM DESIGN TO THERAPEUTIC APPLICATION
Chan, J. H., Lim, S., & Wong, W. F. (2006) · Clinical and Experimental Pharmacology and Physiology · doi:10.1111/j.1440-1681.2006.04403.x · Cited by 430
Surface-Engineered Dendrimers in Gene Delivery
Yang, J., Zhang, Q., Chang, H., & Cheng, Y. (2015) · Chemical Reviews · doi:10.1021/cr500542t · Cited by 429
Mechanisms and strategies for effective delivery of antisense and siRNA oligonucleotides
Juliano, R., Alam, M. R., Dixit, V., & Kang, H. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn342 · Cited by 429
Drug complexation, in vitro release and cellular entry of dendrimers and hyperbranched polymers
Kolhe, P. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(03)00225-4 · Cited by 412
Newkome, G. R., & Shreiner, C. D. (2008) · Polymer · doi:10.1016/j.polymer.2007.10.021 · Cited by 368
Peptide and Amide Bond-Containing Dendrimers
Crespo, L., Sanclimens, G., Pons, M., Giralt, E., Royo, M., & Albericio, F. (2005) · Chemical Reviews · doi:10.1021/cr030449l · Cited by 356
Transcytosis of nanoparticle and dendrimer delivery systems: evolving vistas
Florence, A. T., & Hussain, N. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00184-3 · Cited by 308
The Development of Functional Non-Viral Vectors for Gene Delivery
Patil, S., Gao, Y.-G., Lin, X., Li, Y., Dang, K., Tian, Y., Zhang, W.-J., Jiang, S.-F., Qadir, A., & Qian, A.-R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215491 · Cited by 263
Engineering of Dendrimer Surfaces to Enhance Transepithelial Transport and Reduce Cytotoxicity
Jevprasesphant, R., Penny, J., Attwood, D., McKeown, N. B., & D'Emanuele, A. (2003) · Pharmaceutical Research · doi:10.1023/a:1026166729873 · Cited by 256
Metadata
- Authors
- Yoo, H.
- Venue
- Nucleic Acids Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-11-01
- Volume
- 28
- Issue
- 21
- Pages
- 4225-4231
- ISSN
- 0305-1048 (ISSN-L)
- 1362-4962
- OpenAlex
- W2029349973
- Cited by
- 181
- References
- 1
- FWCI
- 18.02
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.